Pulmonary arterial hypertension–associated cerebellar impairment extends evidence linking cardiometabolic and neurodegenerative diseases
Journal of Clinical Investigation · 02.11.2026 · 136 (21)
DOI: 10.1172/jci212006 ↗Kurz gefasst
Kommentar in der Zeitschrift Journal of Clinical Investigation, online erschienen am 02.11.2026. Verfasst von Michael W Schwartz und 1 weiteren Autor:innen. Beteiligte Einrichtung: Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, UW Medicine Diabetes Institute, and. Hauptthemen laut MEDLINE: Microglia, Neurodegenerative Diseases, Hypertension, Pulmonary, Cerebellar Diseases. Die Arbeit nennt 21 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NHLBI NIH HHS.
Abstract (Originalsprache)
Growing evidence shows that the risk of cognitive impairment is increased across a range of metabolic and cardiovascular diseases, but underlying mechanisms remain poorly understood. One possibility involves activation of microglia, a glial cell type of the central nervous system with morphological and transcriptional features comparable to resident macrophages in other tissues that plays specialized roles in supporting neuronal and brain function. Combining clinical investigation in pulmonary arterial hypertension (PAH) cohorts with mouse model and microglial cell culture studies, a study by Okawa, Shi, and colleagues in this issue of the JCI adds compelling, albeit indirect, evidence linking impaired lysosomal lipid handling in both endothelial cells and microglia to a specific neurological disorder associated with PAH. The findings open opportunities for understanding how cardiopulmonary disease predisposes to neurodegeneration.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Division of Metabolism, Endocrinology and Nutrition, Department of Medicine, UW Medicine Diabetes Institute, and.
- Department of Laboratory Medicine and Pathology, University of Washington, Seattle, Washington, USA.
Förderung
- NIDDK NIH HHS
- NHLBI NIH HHS
Zitieren
APA
Schwartz, M. W., & Bornfeldt, K. E. (2026). Pulmonary arterial hypertension–associated cerebellar impairment extends evidence linking cardiometabolic and neurodegenerative diseases. Journal of Clinical Investigation, 136(21). https://doi.org/10.1172/jci212006
Vancouver
Schwartz MW, Bornfeldt KE. Pulmonary arterial hypertension–associated cerebellar impairment extends evidence linking cardiometabolic and neurodegenerative diseases. Journal of Clinical Investigation. 2026;136(21). doi:10.1172/jci212006
BibTeX
@article{Schwartz2026,
author = {Schwartz, Michael W and Bornfeldt, Karin E},
title = {Pulmonary arterial hypertension–associated cerebellar impairment extends evidence linking cardiometabolic and neurodegenerative diseases},
journal = {Journal of Clinical Investigation},
year = {2026},
volume = {136},
number = {21},
doi = {10.1172/jci212006}
}
EUVIMED